ZA888123B - Disulfur analogs of ll-e33288 antitumor agents - Google Patents

Disulfur analogs of ll-e33288 antitumor agents

Info

Publication number
ZA888123B
ZA888123B ZA888123A ZA888123A ZA888123B ZA 888123 B ZA888123 B ZA 888123B ZA 888123 A ZA888123 A ZA 888123A ZA 888123 A ZA888123 A ZA 888123A ZA 888123 B ZA888123 B ZA 888123B
Authority
ZA
South Africa
Prior art keywords
disulfur
analogs
antitumor agents
antitumor
agents
Prior art date
Application number
ZA888123A
Other languages
English (en)
Inventor
William James Mcgahren
James Mcgahren William
Martin Leon Sassiver
Leon Sassiver Martin
George A Ellestad
A Ellestad George
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA888123B publication Critical patent/ZA888123B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA888123A 1987-10-30 1988-10-28 Disulfur analogs of ll-e33288 antitumor agents ZA888123B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11494087A 1987-10-30 1987-10-30

Publications (1)

Publication Number Publication Date
ZA888123B true ZA888123B (en) 1989-07-26

Family

ID=22358378

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA888123A ZA888123B (en) 1987-10-30 1988-10-28 Disulfur analogs of ll-e33288 antitumor agents
ZA888127A ZA888127B (en) 1987-10-30 1988-10-28 Targeted forms of methyltrithio antitumor agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA888127A ZA888127B (en) 1987-10-30 1988-10-28 Targeted forms of methyltrithio antitumor agents

Country Status (19)

Country Link
EP (2) EP0313874B1 (ko)
JP (2) JP2820256B2 (ko)
KR (2) KR0133130B1 (ko)
AR (1) AR246083A1 (ko)
AT (2) ATE112172T1 (ko)
AU (2) AU612714B2 (ko)
BR (1) BR1100939A (ko)
CA (1) CA1321582C (ko)
DE (2) DE3889063T2 (ko)
DK (2) DK602488A (ko)
ES (2) ES2061586T3 (ko)
FI (2) FI95204C (ko)
HK (2) HK131897A (ko)
IE (2) IE65053B1 (ko)
IL (2) IL87947A (ko)
NO (2) NO176480C (ko)
NZ (2) NZ226727A (ko)
PT (2) PT88882B (ko)
ZA (2) ZA888123B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079233A (en) * 1987-01-30 1992-01-07 American Cyanamid Company N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
US5606040A (en) * 1987-10-30 1997-02-25 American Cyanamid Company Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group
IL115770A (en) * 1989-04-14 1999-03-12 American Cyanamid Co Substituted disulfides of formula q-sp-ss-w their preparation and use for inhibiting the growth of tumours and for treating bacterial infections
GB9007384D0 (en) * 1990-04-02 1990-05-30 Duncan Ruth Coupling between polymers and other organic molecular entities utilising thiol-specific reactive groups
US5712374A (en) * 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
US5714586A (en) * 1995-06-07 1998-02-03 American Cyanamid Company Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
US20040009535A1 (en) 1998-11-27 2004-01-15 Celltech R&D, Inc. Compositions and methods for increasing bone mineralization
PT2261335T (pt) 1998-11-27 2017-09-08 Ucb Pharma Sa Composições e métodos para aumentar a mineralização óssea
NZ511705A (en) * 2001-05-14 2004-03-26 Horticulture & Food Res Inst Methods and rapid immunoassay device for detecting progesterone and other steroids
MEP2808A (xx) 2003-06-16 2010-02-10 Celltech R & D Inc Antitijela specifična za sklerositin i metode za povećanje mineralizacije kostiju
US8841092B2 (en) * 2006-08-30 2014-09-23 Wisconsin Alumni Research Foundation Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods
KR100979928B1 (ko) * 2008-07-16 2010-09-03 한주학 수직축형 부력풍차
SI3066074T1 (sl) * 2013-11-04 2020-03-31 Pfizer Inc. Intermediati in postopki za sintetizacijo derivatov kaliheamicina
EP3573995A1 (en) * 2017-01-24 2019-12-04 Pfizer Inc. Calicheamicin derivatives and antibody drug conjugates thereof
EP3924387A2 (en) * 2019-02-15 2021-12-22 University Of Southern California Lym-1 and lym-2 antibody compositions and improved car constructs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430943A1 (fr) * 1978-07-13 1980-02-08 Toyo Jozo Kk Nouveaux derives disulfures
DE3175151D1 (en) * 1980-05-21 1986-09-25 Teijin Ltd Reactive polymer and process for the preparation thereof
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
CA1314245C (en) * 1984-05-23 1993-03-09 Franz Jansen Process for the preparation of conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, which are useful as immunotoxin potentiators
DE3588213T2 (de) * 1984-11-16 1999-09-30 American Cyanamid Co Antitumorale Antibiotika (Komplex LL-E-33288)
EP0330874A3 (en) * 1988-02-29 1989-10-18 American Cyanamid Company Antibacterial and antitumor agents LL-E33288 epsilon-I and LL-E33288-epsilonBr, with processes and intermediates for producing said agents
EP0342341A3 (en) * 1988-05-17 1991-07-24 American Cyanamid Company Process for producing antitumor antibiotic ll-e33288gamma2

Also Published As

Publication number Publication date
HK131897A (en) 1997-10-03
NO176480C (no) 1995-04-12
EP0313874A3 (en) 1990-05-09
IE883261L (en) 1989-04-30
AU2449488A (en) 1989-05-04
NO176480B (no) 1995-01-02
FI884983A0 (fi) 1988-10-28
JP2720933B2 (ja) 1998-03-04
NO884834D0 (no) 1988-10-28
NO884833D0 (no) 1988-10-28
FI91262B (fi) 1994-02-28
KR970011385B1 (ko) 1997-07-10
DK602488D0 (da) 1988-10-28
ATE104309T1 (de) 1994-04-15
JP2820256B2 (ja) 1998-11-05
NO884834L (no) 1989-05-02
NO173506C (no) 1993-12-22
ZA888127B (en) 1989-07-26
DE3889063T2 (de) 1994-12-01
ATE112172T1 (de) 1994-10-15
IL87946A0 (en) 1989-03-31
DE3851682T2 (de) 1995-05-04
AR246083A1 (es) 1994-03-30
PT88882B (pt) 1993-01-29
KR890006245A (ko) 1989-06-12
DK602588A (da) 1989-05-01
IL87947A (en) 1995-05-26
FI884984A0 (fi) 1988-10-28
IE883262L (en) 1989-04-30
DK602588D0 (da) 1988-10-28
IL87947A0 (en) 1989-03-31
CA1321582C (en) 1993-08-24
IL87946A (en) 1995-06-29
AU612714B2 (en) 1991-07-18
FI95204B (fi) 1995-09-29
HK131997A (en) 1997-10-03
JPH01193282A (ja) 1989-08-03
DE3889063D1 (de) 1994-05-19
EP0313873B1 (en) 1994-09-28
DK174739B1 (da) 2003-10-13
AU618763B2 (en) 1992-01-09
AU2448988A (en) 1989-05-04
NO173506B (no) 1993-09-13
EP0313874A2 (en) 1989-05-03
NZ226726A (en) 1991-08-27
PT88881B (pt) 1993-01-29
NZ226727A (en) 1991-12-23
IE65989B1 (en) 1995-11-29
FI884984A (fi) 1989-05-01
EP0313874B1 (en) 1994-04-13
ES2061586T3 (es) 1994-12-16
FI884983A (fi) 1989-05-01
DE3851682D1 (de) 1994-11-03
ES2059464T3 (es) 1994-11-16
DK602488A (da) 1989-05-01
FI95204C (fi) 1996-01-10
EP0313873A1 (en) 1989-05-03
KR0133130B1 (ko) 1998-04-17
KR890006244A (ko) 1989-06-12
FI91262C (fi) 1994-06-10
BR1100939A (pt) 1999-08-31
IE65053B1 (en) 1995-10-04
JPH0296599A (ja) 1990-04-09
NO884833L (no) 1989-05-02

Similar Documents

Publication Publication Date Title
JPS6468373A (en) Therapeutical nucleoside
EP0313874A3 (en) Disulfur analogs of ll-e33288 antitumor agents
GB8725334D0 (en) Preparation of benzothiazole-2-sulphenamides
EP0295361A3 (en) Preparation of pseudoionones
GB8723048D0 (en) Polyetherimides
ZA886812B (en) Anti-tumor prodrugs
YU146288A (en) Derivatives of benzimidazole-2-il-pyridinium
GB2217729B (en) Obtenation of scualane
GB2193701B (en) Forming lines of cigarettes
GB8703015D0 (en) Aminopeptidase
IL85656A0 (en) Preparation of phenylacetaldehydes
JPS6490139A (en) Synthesis of cis-9-tricocene
GB2205313B (en) Preparation of trifluoromethyltoluene from halomethylbenzotrifluoride
GB8705811D0 (en) Inositol derivatives
EP0307189A3 (en) Combination of slide members
GB8720379D0 (en) Preparation of butenes
EP0262852A3 (en) Prodrugs of antihypercholoesterolemic compounds
GB2201674B (en) Preparation of triperfluoroalkylamines
GB8501046D0 (en) Mechanism for moving extremities of dolls
IL85721A0 (en) Pyridyldiazabutadienyl disulfides
IL86474A0 (en) Dehydrobromination of substituted alpha-halocumene
JPS6429395A (en) Adenosine compound
IE872159L (en) Antitumor agent
BG43251A1 (en) Derivatives of chloracetamide
GB8701889D0 (en) Determination of position